Jon Brock is a former autism researcher who is now a science writer, medical grant writer and co-founder of Frankl Open Science.
Jon Brock
Research fellow
Macquarie University
From this contributor
Virtual reality yields clues to social difficulties in autism
Assessing social ability in adults with autism requires controlled tests involving real-time social interactions. Virtual reality makes this possible.
Virtual reality yields clues to social difficulties in autism
By
Nathan Caruana, Jon Brock
16 May 2017 | 8 min read
Quest for autism biomarkers faces steep statistical challenges
Finding a difference between people with and without autism is only the first step toward identifying a clinically useful marker of the condition.
The elusive essence of autism
Researchers must make heterogeneity in autism the object of their investigation, rather than treating it as an excuse for inconsistent results or an inconvenience in their quest to understand the disorder’s essence, argues Jon Brock.
Registered reports
The more researchers poke around, the more likely they are to find a significant effect — and the more likely that the effect they end up reporting is just a fluke. A new kind of journal article, the 'registered report,' may address this problem, says Jon Brock.
Six questions for connectivity theory research
'Underconnectivity' is considered one of the best-supported theories for the neural basis of autism. But many questions remain unanswered, says Jon Brock.
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read